Australia markets closed

BCAL Diagnostics Limited (BDX.XA)

CXA - CXA Real-time price. Currency in AUD
Add to watchlist
0.08000.0000 (0.00%)
At close: 12:17PM AEDT
Full screen
Previous close0.0800
Bid0.0680 x N/A
Ask0.0940 x N/A
Day's range0.0800 - 0.0800
52-week range0.0800 - 0.0800
Avg. volumeN/A
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    BCAL Files Foundational Patent Application

    New lipid biomarkers central to development of breast cancer diagnostic blood test are coveredPatent application will underpin future global filings securing key features of BCAL’s test SYDNEY, Australia, May 11, 2022 (GLOBE NEWSWIRE) -- Breast cancer screening and diagnostic company BCAL Diagnostics Limited (ASX:BDX, ‘BCAL’ or the ‘Company’) is pleased to announce the filing of a provisional patent application number 2022901245 at IP Australia covering key lipid biomarkers that form part of its

  • Simply Wall St.

    Companies Like BCAL Diagnostics (ASX:BDX) Are In A Position To Invest In Growth

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

  • GlobeNewswire

    Asure’s Payroll Fintech Powers New Treasury System to Deliver Added Value to Business Customers

    AUSTIN, Texas, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Asure Software, Inc., (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management (“HCM”) software solutions, today announced the launch of an advanced Treasury Management System to bring world-class automation to its preparation and reconciliation of business customers’ daily cash position. “Automating the ins and outs of money movement and the reconciliation of payroll funds in our new Treasury System sets us up to take advantage